Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
  • Getting new auth cookie, if you see this message a lot, tell someone!
  • Getting new auth cookie, if you see this message a lot, tell someone!
Research

Pediatric drug data in Canadian drug monographs: a descriptive analysis

Preeya Raja, Mark Duffett, Maryann Mazer-Amirshahi, Ashaka Patel, Andrea Gilpin, Catherine Litalien, Anthony K. Chan, John van den Anker, Thierry Lacaze-Masmonteil and Samira Samiee-Zafarghandy
August 31, 2020 8 (3) E522-E529; DOI: https://doi.org/10.9778/cmajo.20200010
Preeya Raja
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
MSc PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Duffett
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryann Mazer-Amirshahi
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
PharmD MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashaka Patel
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
BHSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Gilpin
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
PhD MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Litalien
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony K. Chan
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John van den Anker
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Lacaze-Masmonteil
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samira Samiee-Zafarghandy
Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 8 no. 3 E522-E529
DOI 
https://doi.org/10.9778/cmajo.20200010
PubMed 
32873580
History 
  • Published online August 31, 2020.
Copyright & Usage 
Copyright 2020, Joule Inc. or its licensors

Author Information

  1. Preeya Raja, MSc PharmD,
  2. Mark Duffett, PhD,
  3. Maryann Mazer-Amirshahi, PharmD MD PhD,
  4. Ashaka Patel, BHSc,
  5. Andrea Gilpin, PhD MBA,
  6. Catherine Litalien, MD,
  7. Anthony K. Chan, MBBS,
  8. John van den Anker, MD PhD,
  9. Thierry Lacaze-Masmonteil, MD PhD,
  10. Samira Samiee-Zafarghandy, MD
  1. Department of Pharmacy (Raja), Hamilton Health Sciences; Departments of Pediatrics (Duffett), and Health Research Methods, Evidence, and Impact (Duffett), McMaster University, Hamilton, Ont.; Department of Emergency Medicine (Mazer-Amirshahi), MedStar Washington Hospital Center, Washington, DC; Faculty of Health Sciences (Patel), McMaster University, Hamilton, Ont.; The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Center (Gilpin, Litalien), Montréal, Que.; Division of Pediatric Hematology/Oncology (Chan), McMaster Children’s Hospital, McMaster University, Hamilton, Ont.; Division of Clinical Pharmacology (van den Anker), Department of Pediatrics, Children’s National Health System, Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics (van den Anker), University of Basel Children’s Hospital, Basel, Switzerland; Division of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children’s Hospital, McMaster University, Hamilton, Ont.
  1. Correspondence to: Samira Samiee-Zafarghandy, samiees{at}mcmaster.ca
View Full Text

Usage statistics: August 2020 to August 2025

AbstractFullPdf
Aug 2020600
Sep 202036249788
Oct 2020858843
Nov 2020357415
Dec 2020306924
Jan 2021223826
Feb 2021255316
Mar 202120359
Apr 202112305
May 20214611511
Jun 2021233718
Jul 202125821
Aug 20213234
Sep 202122322
Oct 202122421
Nov 202133329
Dec 202122912
Jan 202253619
Feb 202232322
Mar 202214524
Apr 202223423
May 202293426
Jun 202224526
Jul 202232419
Aug 202292522
Sep 202231623
Oct 202213025
Nov 202233424
Dec 202251212
Jan 202322418
Feb 20234169
Mar 202343113
Apr 202332017
May 202322116
Jun 202312124
Jul 202312623
Aug 202305419
Sep 202332816
Oct 202314118
Nov 202306625
Dec 202359223
Jan 2024840118
Feb 20246167
Mar 202435323
Apr 202423524
May 202452349
Jun 202466015
Jul 202465715
Aug 202435315
Sep 202434436
Oct 202464432
Nov 202424121
Dec 202443628
Jan 202541821
Feb 202502321
Mar 202535441
Apr 202515529
May 202546334
Jun 202514728
Jul 2025448537
Aug 202566633
PreviousNext
Back to top

In this issue

CMAJ Open: 8 (3)
Vol. 8, Issue 3
1 Jul 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pediatric drug data in Canadian drug monographs: a descriptive analysis
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pediatric drug data in Canadian drug monographs: a descriptive analysis
Preeya Raja, Mark Duffett, Maryann Mazer-Amirshahi, Ashaka Patel, Andrea Gilpin, Catherine Litalien, Anthony K. Chan, John van den Anker, Thierry Lacaze-Masmonteil, Samira Samiee-Zafarghandy
Jul 2020, 8 (3) E522-E529; DOI: 10.9778/cmajo.20200010

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pediatric drug data in Canadian drug monographs: a descriptive analysis
Preeya Raja, Mark Duffett, Maryann Mazer-Amirshahi, Ashaka Patel, Andrea Gilpin, Catherine Litalien, Anthony K. Chan, John van den Anker, Thierry Lacaze-Masmonteil, Samira Samiee-Zafarghandy
Jul 2020, 8 (3) E522-E529; DOI: 10.9778/cmajo.20200010
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Le temps est venu de mettre en œuvre un cadre de reglementation en matiere de medicaments a usage pediatrique au Canada
  • Time for a regulatory framework for pediatric medications in Canada
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Critical Care, Intensive Care
      • Neonatal
      • Pediatric
    • Pediatrics
      • Other pediatrics
    • Drugs
      • Regulation

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire